The Role of RASs /RVs in the Current Management of HCV

The approval of combination therapies with direct-acting antiviral (DAA) regimens has led to significant progress in the field of hepatitis C virus (HCV) treatment. Although most patients treated with these agents achieve a virological cure, resistance to DAAs is a major issue. The rapid emergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Malandris, Konstantinos, Kalopitas, Georgios, Theocharidou, Eleni, Germanidis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539246/
https://www.ncbi.nlm.nih.gov/pubmed/34696525
http://dx.doi.org/10.3390/v13102096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539246/
https://www.ncbi.nlm.nih.gov/pubmed/34696525
http://dx.doi.org/10.3390/v13102096

Ejemplares similares